Results 11 to 20 of about 16,378 (224)

The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review [PDF]

Терапевтический архив, 2018
This case is the first description of the successful anti-B-cell therapy with rituximab in a patient with Sjogrenʼs syndrome and neuromyelitis optica spectrum disorder in Russia.
A V Torgashina, V I Vasilyev
doaj   +1 more source

Fahr’s syndrome as a manifestation of autoimmune polyendocrine syndrome-1 and its unusual association with neuromyelitis optica spectrum disorder

Frontiers in Neuroscience, 2023
Fahr’s syndrome, also known as bilateral striopallidodendate calcinosis, is a rare inherited neurodegenerative illness characterized by abnormal calcium deposition in several areas of the brain, resulting in a wide range of neuropsychological symptoms ...
Ahmad Nawaz, Azba Ahmad, Ayesha Aslam, Safia Bano, Ahsan Numan, Eisham Sarmad   +5 more
doaj   +1 more source

Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families

Frontiers in Pediatrics, 2022
Biotinidase deficiency is an autosomal recessive, multiple carboxylase deficiency usually associated with seizures, eczema, hypotonia, visual disturbances, hearing loss, and developmental delays. Only a handful of cases of biotinidase deficiency that had
Muhammad Imran Naseer, Muhammad Imran Naseer, Peter Natesan Pushparaj, Peter Natesan Pushparaj, Peter Natesan Pushparaj, Angham Abdulrahman Abdulkareem, Angham Abdulrahman Abdulkareem, Osama Y. Muthaffar   +7 more
doaj   +1 more source

Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience

Arquivos de Neuro-Psiquiatria, 2023
Background Anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibody-associated disease (MOGAD) is an immune-mediated neurological disorder with a broad spectrum of clinical presentation that is often difficult to distinguish from other ...
Katharina Messias, Renata Moreto, Camila Aquino Cruz, Nathalia Rossoni Ronchi, Antonio Carlos dos Santos, André Messias, Vanessa Daccach Marques   +6 more
doaj   +1 more source

Pathophysiologisch-serologische, bildgebende und klinische Charakteristika der Neuromyelitis Optica [PDF]

, 2019
Hintergrund: Neuromyelitis optica-Spektrum-Erkrankungen (NMOSD) stellen eine Gruppe neuroinflammatorischer Erkrankungen dar, die mit dem klinischen Auftreten von Myelitiden und/oder Optikusneuritiden (ON) einhergeht.
Schumacher, Sophie
core   +1 more source

Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report

Journal of Medical Case Reports, 2019
Background Neuromyelitis optica spectrum disorders are severe autoimmune inflammatory diseases of the central nervous system associated with the presence of immunoglobulin G antibodies against the water channel protein aquaporin-4.
Susanne Bejerot, Eva Hesselmark, Fariborz Mobarrez, Håkan Wallén, Max Albert Hietala, Rolf Nybom, Lennart Wetterberg   +6 more
doaj   +1 more source

Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders [PDF]

, 2019
The detection of IgG aquaporin-4 antibodies in the serum of patients with Neuromyelitis optica (NMO) has dramatically improved the diagnosis of this disease and its distinction from multiple sclerosis.
Abril-Jaramillo, Javier, Casado Chocán, José Luis, Díaz Sánchez, María, Echevarría Irusta, Miriam, García Miranda, Pablo, García Sánchez, María Isabel, Lamas-Pérez, Lucía, Lebrato-Hernández, Lucía, Martínez Olivo, María del Mar, Morón Civanto, Francisco Jesús, Navarro, Gemma, Ramírez Lorca, Reposo, Romera, Mercedes, Suárez-Luna, Nela, Uclés Sánchez, Antonio José   +14 more
core   +1 more source

Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder. [PDF]

, 2016
OBJECTIVE: To study rituximab in pediatric neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) and the relationship between rituximab, B cell repopulation, and relapses in order to improve rituximab monitoring and redosing.
Alper, G, Appleton, R, Banwell, B, Benson, La, Brilot, F, Dale, R. C., Deiva, K, Gorman, Mp, Leventer, Rj, Mohammad, Ss, Nolan, M, Nosadini, M, Ramanathan, S, Riney, Cj, Waldman, At   +14 more
core   +1 more source

Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder

Frontiers in Neurology, 2022
Background and ObjectivesTo describe a new case of neuromyelitis optica spectrum disorder (NMOSD) induced by the administration of interferon-alpha (IFNα) and to raise awareness of this rare drug-induced disease of IFNα treatment.MethodsA single case ...
Jie Rao, Na Xu, Jing Sun, Yan Li, Fangwang Fu   +4 more
doaj   +1 more source

Higher frequency of brain abnormalities in neuromyelitis optica spectrum disorder patients without primary Sjögren′s syndrome

Neural Regeneration Research, 2016
Neuromyelitis optica spectrum disorder often co-exists with primary Sjögren′s syndrome. We compared the clinical features of 16 neuromyelitis optica spectrum disorder patients with (n = 6) or without primary Sjögren′s syndrome (n = 10).
Li-na Gu, Min Zhang, Hui Zhu, Jing-yao Liu   +3 more
doaj   +1 more source